4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001209191-23-024335
Chief Legal Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sullivan Mark Chief Legal Officer | 2023-04-13 | Grant or award | +200,000 | 200,000 | D |
Loading xslF345X04/doc4.xml…